Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Agriculture
- Branch
- National Institute of Food and Agriculture
- Recipient company
- Poplar Innovations Inc.
- Proposal award date
- 2024-01-29
- Contract end date
- 2025-02-28
- UEI
- QKUJCLDJEQW3
- Solicitation number
- USDA-NIFA-SBIR-009962
- Topic code
- 8.1
Research abstract
Hybrid poplar is the predominant woody perennial being developed for the bioeconomy as a
purpose-grown source of cellulosic feedstock. P. deltoides — P. trichocarpa has been the most
productive hybrid in the Northwest while P. deltoides — P. maximowiczii is likely the
Southeast's best hybrid. But durable disease resistance is the principal obstacle in continued
commercial use of these hybrids. Breeding for resistance to Melampsora leaf rust the main
pathogen in the Northwest has been difficult due to the multiplicity of rust pathotypes. In the
Southeast attaining resistance to the principal pathogen Septoria stem canker has been
challenging given the disease's broad range of virulence. Our goal is the development of
endophyte-mediated resistance technology to overcome these pathogens either by direct
antagonism or by prompting host-resistance mechanisms. The proposal therefore responds to
program area 8.1's priority to develop "… better methods [and] control strategies for combating
… pathogens that attack important woody species…" The objectives are: 1) identification of
bacterial endophytes that are antagonistic to Melampsora and Septoria in laboratory and
greenhouse assays and 2) evaluation of endophyte technology in hybrid trials in the Northwest
and the Southeast. George Newcombe will provide expertise in endophyte selection and
application. Anticipated results are improved disease control methods that augment genetic
resistance. Phase I will be devoted to endophyte discovery and establishment of field trials.
Phase II will complete the fields trials. Phase III's objective is the joint commercialization of
hybrids and endophytes in the two regions.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
2 SBIR/STTR records share this UEI (2024–2025). Reported award amounts total $349,929. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Agriculture
Agency intelligence
Department of Agriculture
Back to SBIR/STTR Research Awards